NCT06531083

Brief Summary

Trismus, or restricted jaw movement, can occur in individuals with head and neck cancer (HNC) undergoing surgery or radiation therapy. There is a paucity of research examining interventions for trismus. We aim to assess the feasibility of prospective surveillance and early intervention to mitigate trismus in individuals undergoing HNC treatment. Method: The investigators will conduct a pilot single group feasibility study involving 30 individuals with HNC who will be undergoing radiation therapy. Participants will be identified at the HNC new patient clinic. Participants will be seen weekly during radiation therapy and will receive early intervention including manual therapy and a device-based jaw exercise regimen if presenting with 5% or greater reduction in jaw opening compared to pre-treatment. The investigators will assess recruitment and completion rates, intervention acceptability, and data collection procedures. Descriptive statistics will summarize feasibility metrics and participant demographics. Findings will inform the design of a larger multicentre trial.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at P25-P50 for not_applicable head-and-neck-cancer

Timeline
1mo left

Started Mar 2025

Shorter than P25 for not_applicable head-and-neck-cancer

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress95%
Mar 2025May 2026

First Submitted

Initial submission to the registry

July 23, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 31, 2024

Completed
7 months until next milestone

Study Start

First participant enrolled

March 1, 2025

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2026

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2026

Expected
Last Updated

February 5, 2026

Status Verified

February 1, 2026

Enrollment Period

11 months

First QC Date

July 23, 2024

Last Update Submit

February 2, 2026

Conditions

Keywords

Physical Therapy

Outcome Measures

Primary Outcomes (1)

  • Feasibility: completion rate

    Number of participants completing the study.

    2 years

Secondary Outcomes (8)

  • Feasibility: recruitment rate

    2 years

  • Feasibility: adherence rate

    6 weeks.

  • Maximal interincisal opening

    3 months

  • Trismus symptom questionnaire

    3 months

  • Quality of life related to Head and Neck Cancer

    3 months

  • +3 more secondary outcomes

Study Arms (1)

Prospective Surveillance for Trismus and Early Physical Therapy Intervention

EXPERIMENTAL

Weekly monitoring of mouth opening and jaw function. Early intervention if the participant presents with 5% or greater reduction in mouth opening compared to pre-treatment measures. Early intervention will comprise: physical therapy, home exercises and use of a jaw stretching device.

Behavioral: Early physical therapy intervention

Interventions

Physical therapy including manual therapy, home exercises for the neck and jaw, and use of a jaw stretching device.

Prospective Surveillance for Trismus and Early Physical Therapy Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Have a diagnosis of oral, oropharyngeal, or nasopharyngeal cancer
  • Be scheduled to undergo cancer treatment that includes radiation therapy
  • Be able to read and understand English
  • Be an Alberta resident.

You may not qualify if:

  • Previous surgery for the temporomandibular joint that is not related to the HNC diagnosis.
  • Local cancer recurrence or metastatic disease.
  • Unable to provide informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Alberta/ Cross Cancer Institute

Edmonton, Alberta, T6G 2G4, Canada

RECRUITING

MeSH Terms

Conditions

Head and Neck NeoplasmsTrismus

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsSpasmNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Margaret McNeely, PhD

    University of Alberta

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Margaret McNeely, PhD

CONTACT

Lynn Mohamad, PhDc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Model Details: Prospective surveillance with early intervention
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 23, 2024

First Posted

July 31, 2024

Study Start

March 1, 2025

Primary Completion

January 31, 2026

Study Completion (Estimated)

May 31, 2026

Last Updated

February 5, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will share

Data will be available on Borealis (University of Alberta)

Shared Documents
STUDY PROTOCOL, ICF
Time Frame
The data will be made available following publication of the primary paper.
Access Criteria
On request from research team

Locations